João Pedro Melo Marques Pinho Ferreira


AuthID: R-00J-GPJ

Confirmed Publications: 349



221
TITLE: Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
AUTHORS: Milton Packer; Javed Butler; Gerasimos Filippatos; Faiez Zannad; Joao Pedro Ferreira ; Cordula Zeller; Martina Brueckmann; Waheed Jamal; Stuart J Pocock; Stefan D Anker;
PUBLISHED: 2020, SOURCE: European Journal of Heart Failure, VOLUME: 22, ISSUE: 12
INDEXED IN: CrossRef: 23
IN MY: ORCID | CIÊNCIAVITAE
222
223
TITLE: Differences in biomarkers and molecular pathways according to age for patients with HFrEF  Full Text
AUTHORS: João Pedro Ferreira ; Wouter Ouwerkerk; Bernadet T Santema; Dirk J van Veldhuisen; Chim C Lang; Leong L Ng; Stefan D Anker; Kenneth Dickstein; Marco Metra; John G F Cleland; Samani J Nilesh; Gerasimos Filippatos; Joseph-Pierre Aboumsallem; Rudolf A de Boer; Sylwia Figarska; Iziah E Sama; Adriaan A Voors; Faiez Zannad;
PUBLISHED: 2020, SOURCE: Cardiovascular Research
INDEXED IN: CrossRef: 6
IN MY: ORCID | CIÊNCIAVITAE
224
TITLE: Distinct Pathological Pathways in Patients With Heart Failure and Diabetes  Full Text
AUTHORS: Jasper Tromp; Adriaan A Voors; Abhinav Sharma; João P Ferreira ; Wouter Ouwerkerk; Hans L Hillege; Karla A Gomez; Kenneth Dickstein; Stefan D Anker; Marco Metra; Chim C Lang; Leong L Ng; Pim van der Harst; Dirk J van Veldhuisen; Peter van der Meer; Carolyn S.P Lam; Faiez Zannad; Iziah E Sama;
PUBLISHED: 2020, SOURCE: JACC: Heart Failure, VOLUME: 8, ISSUE: 3
INDEXED IN: CrossRef: 25
IN MY: ORCID | CIÊNCIAVITAE
225
TITLE: Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial  Full Text
AUTHORS: Pierpaolo Pellicori; João Pedro Ferreira ; Beatrice Mariottoni; Hans‐Peter Brunner‐La Rocca; Fozia Z Ahmed; Job Verdonschot; Tim Collier; Joe J Cuthbert; Johannes Petutschnigg; Blerim Mujaj; Nicolas Girerd; Arantxa González; Andrew L Clark; Franco Cosmi; Jan A Staessen; Stephane Heymans; Roberto Latini; Patrick Rossignol; Faiez Zannad; John G.F Cleland;
PUBLISHED: 2020, SOURCE: European Journal of Heart Failure, VOLUME: 22, ISSUE: 9
INDEXED IN: CrossRef: 44
IN MY: ORCID | CIÊNCIAVITAE
226
TITLE: Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
AUTHORS: João Pedro Ferreira ; David Fitchett; Anne Pernille Ofstad; Bettina Johanna Kraus; Christoph Wanner; Isabella Zwiener; Bernard Zinman; Sabine Lauer; Jyothis T George; Patrick Rossignol; Faiez Zannad;
PUBLISHED: 2020, SOURCE: American Journal of Hypertension, VOLUME: 33, ISSUE: 12
INDEXED IN: CrossRef: 26
IN MY: ORCID | CIÊNCIAVITAE
227
TITLE: Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)  Full Text
AUTHORS: Stienen, S; Ferreira, JP ; Kobayashi, M; Preud'homme, G; Dobre, D; Machu, JL; Duarte, K; Bresso, E; Devignes, MD; Lopez, N; Girerd, N; Aakhus, S; Ambrosio, G; Brunner La Rocca, HP; Fontes Carvalho, R ; Fraser, AG; van Heerebeek, L; Heymans, S; de Keulenaer, G; Marino, P; McDonald, K; Mebazaa, A; Papp, Z; Raddino, R; Tschope, C; Paulus, WJ; Zannad, F; Rossignol, P; ...More
PUBLISHED: 2020, SOURCE: BIOMARKERS, VOLUME: 25, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 28
IN MY: ORCID | CIÊNCIAVITAE
228
TITLE: Estimating lifetime benefits of comprehensive disease -modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials  Full Text
AUTHORS: Vaduganathan, M; Claggett, BL; Jhund, PS; Cunningham, JW; Ferreira, JP ; Zannad, F; Packer, M; Fonarow, GC; McMurray, JJV; Solomon, SD;
PUBLISHED: 2020, SOURCE: LANCET, VOLUME: 396, ISSUE: 10244
INDEXED IN: Scopus WOS CrossRef: 409
IN MY: ORCID | CIÊNCIAVITAE
229
TITLE: Estimating the Lifetime Benefits of Treatments for Heart Failure  Full Text
AUTHORS: João Pedro Ferreira ; Kieran F Docherty; Susan Stienen; Pardeep S Jhund; Brian L Claggett; Scott D Solomon; Mark C Petrie; John Gregson; Stuart J Pocock; Faiez Zannad; John J.V McMurray;
PUBLISHED: 2020, SOURCE: JACC: Heart Failure, VOLUME: 8, ISSUE: 12
INDEXED IN: CrossRef: 16
IN MY: ORCID | CIÊNCIAVITAE
230
TITLE: Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study  Full Text
AUTHORS: Carlo Mario Lombardi; João Pedro Ferreira ; Valentina Carubelli; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos Filippatos; Chim C Lang; Leong L Ng; Piotr Ponikowski; Nilesh J Samani; Dirk J van Veldhuisen; Faiez Zannad; Adriaan Voors; Marco Metra;
PUBLISHED: 2020, SOURCE: Clinical Research in Cardiology, VOLUME: 109, ISSUE: 8
INDEXED IN: CrossRef: 8
IN MY: ORCID | CIÊNCIAVITAE
Page 23 of 35. Total results: 349.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service